贝泰妮 reported revenue of ¥2.59B for the period ended 2026-06-30, +9.3% year on year. Net income was ¥0.29B, a 11.1% net margin on a 74.6% gross margin. The largest revenue line is 护肤品 at 88% of the total. Free cash flow for the period was ¥0.34B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.59B | +9.3% |
| Gross profit | ¥1.93B | — |
| Operating income | ¥0.35B | — |
| Net income | ¥0.29B | +15.5% |
| Gross margin | 74.6% | Net margin 11.1% |
| Revenue Q/Q | +31.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 护肤品 | ¥2.28B | 87.9% |
| 彩妆 | ¥0.19B | 7.3% |
| 医疗器械 | ¥0.07B | 2.5% |
| 服务及其他 | ¥0.06B | 2.3% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.66B | 25.4% |
| R&D | ¥0.11B | 4.3% |
| SG&A | ¥1.51B | 58.2% |
| Tax & other | ¥0.07B | 2.6% |
| Item | Amount |
|---|---|
| Total assets | ¥8.19B |
| Total liabilities | ¥1.95B |
| Shareholders' equity | ¥6.24B |
| Equity / assets | 76.2% |
| Operating cash flow | ¥0.35B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.34B |
| Cash conversion (OCF / net income) | 137% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
建工修复 ・ 线上线下 ・ 通业科技 ・ 深水海纳 ・ 中金辐照 ・ 中洲特材 ・ 本川智能 ・ 恒宇信通 ・ 共同药业 ・ 晓鸣股份 ・ 格林精密 ・ 恒帅股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies